U.S. AI in Biotechnology Market to Soar by 2034
The U.S. artificial intelligence in biotechnology market is on a rocket-fueled growth trajectory. Analysts expect the market value to jump from USD 2.10 billion in 2025 to a whopping USD 10.46 billion by 2034. That’s a compound annual growth rate (CAGR) of 19.51%—a pace that could make even the most energetic biotech researchers need an extra cup of coffee.
Why Is AI Revolutionizing Biotechnology?
AI is shaking up the biotech sector, driving innovation in research, drug discovery, and personalized healthcare. Venture capital is pouring in, and companies are racing to tap into AI’s power to analyze massive datasets, find new treatment targets, and speed up the entire R&D process. If you’re imagining lab coats and robots working side-by-side to cure diseases faster than you can say “double helix,” you’re not far off.
This growth isn’t just impressive—it’s inspiring. AI-powered biotech could lead to life-saving breakthroughs, making the future of medicine look brighter (and maybe a little more robotic). So, whether you’re an investor, a scientist, or just a fan of sci-fi, keep an eye on this space. The coming decade could be legendary for U.S. biotech and AI.
Sources:
https://www.precedenceresearch.com/us-artificial-intelligence-in-biotechnology-market
